优化RNA干扰疗法结合interleukin-2mRNA用于治疗乙型肝炎病毒感染
Wenjing Zai1, Min Yang2,3, Kuan Jiang2,4
1Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), Research Unit of Cure of Chronic Hepatitis B Virus Infection (CAMS), Shanghai Frontiers Science Center of Pathogenic Microbes and Infection, School of Basic Medical Sciences, Shanghai Medical College, Fudan University, Shanghai, P. R. China.
Signal transduction and targeted therapy
|June 20, 2024
概括
这项研究开发了一种有效的脂质纳米粒子 (LNP) 输送系统,用于小干扰RNA (siRNA) 治疗慢性乙型肝炎 (CHB). 组合疗法显示显著的病毒减少和免疫反应,提供了一个有前途的新治疗策略.
科学领域:
- 肝病学和病毒学.
- RNA疗法和药物输送
背景情况:
- 慢性乙型肝炎 (CHB) 仍然是一个重大的全球健康挑战,需要新的治疗策略.
- 目前的治疗方法通常可以抑制病毒,但不能完全治愈,这凸显了需要更有效的方法.
- RNA干扰 (RNAi) 为向病毒RNA提供了一个强有力的机制,但有效的传递对于治疗成功至关重要.
研究的目的:
- 开发一种泛基因型的小干扰RNA (siRNA),以向乙型肝炎病毒 (HBV),用于治疗CHB.
- 优化脂质纳米粒子 (LNP) 输送系统,以提高siRNA的有效性和安全性.
- 研究RNAi和免疫调制 (通过小鼠IL-2 mRNA) 的联合疗效,以改善病毒控制.
主要方法:
- 设计和评估20个合成siRNAs与保存的HBV基因组区域对比.
- 使用特定脂质 (HO-PEG2000-DMG) 和聚乙烯糖醇 (PEG) 脂质比率优化LNP配方.
- 在rAAV-HBV1.3小鼠模型中,对优化LNP携带siRNA (tLNP/siHBV) 和与小鼠IL-2 mRNA (tLNP/siHBVIL2) 携带siRNA的体内疗效和安全性评估.
主要成果:
- 一种选择的siRNA组合 (siHBV) 实现了98.55%的基因型覆盖率.
- 优化的LNP配方 (tLNP) 有效地释放了siHBV,以剂量和时间依赖的方式显著减少HBV抗原和DNA (高达3-log10减少),并具有良好的安全性.
- 同时提供siHBV和mIL-2mRNA (tLNP/siHBVIL2) 证明了协同控制,实现HBsAg清除和强大的HBV特异性CD4+和CD8+T细胞反应.
结论:
- 开发的tLNP/siHBV配方为CHB提供了基于RNAi的强效和安全的治疗策略.
- 通过tLNP同时输送siHBV和mIL-2mRNA,通过联合抗原降低和免疫刺激来增强病毒控制.
- 这种双模式的方法代表了一种有前途的转化策略,用于有效治疗慢性乙型肝炎.
相关概念视频
Experimental RNAi
6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
siRNA - Small Interfering RNAs
16.7K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.7K
Tumor Immunotherapy
511
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
511
Leaky Scanning
5.1K
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.1K


